1/22
04:00 pm
plrx
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1/22
08:00 am
plrx
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Medium
Report
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
1/2
08:00 am
plrx
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
11/21
08:00 am
plrx
Pliant Therapeutics to Participate in Upcoming Investor Events
Low
Report
Pliant Therapeutics to Participate in Upcoming Investor Events
11/18
06:00 pm
plrx
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
Medium
Report
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
11/8
12:31 pm
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
11/7
04:18 pm
plrx
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/7
04:05 pm
plrx
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Low
Report
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
1/22
06:07 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Coulie Bernard
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Coulie Bernard
1/22
06:05 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Cummings Keith Lamont
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Cummings Keith Lamont
1/22
06:02 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Hull Hans
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Hull Hans
1/22
06:00 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Lefebvre Eric
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Lefebvre Eric
1/22
05:58 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Cheung Lily
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Cheung Lily
1/22
05:55 pm
plrx
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Ouimette Mike
Medium
Report
Form 4 PLIANT THERAPEUTICS, For: Jan 17 Filed by: Ouimette Mike
1/22
04:24 pm
plrx
Form 144 PLIANT THERAPEUTICS, Filed by: Ouimette Mike
Medium
Report
Form 144 PLIANT THERAPEUTICS, Filed by: Ouimette Mike
11/14
09:01 pm
plrx
Form SC 13G PLIANT THERAPEUTICS, Filed by: Redmile Group, LLC
Low
Report
Form SC 13G PLIANT THERAPEUTICS, Filed by: Redmile Group, LLC
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register